EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of long‐term survivors with liver metastases from uveal melanoma diagnosed between 2005 and 2021

Jona Laukhuf, Lisa Wiens, Gerd Grözinger, Helmut Dittmann, Karolin Thiel, Ulrike Leiter, Teresa Amaral, Lena Nanz, Lukas Flatz, Markus Reitmajer, Andrea Forschner iD

International Journal of Cancer · 2026

DOI: 10.1002/ijc.70246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Jona Laukhuf und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. Hauptthemen laut MEDLINE: Melanoma, Uveal Neoplasms, Liver Neoplasms, Cancer Survivors. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Junior Clinician Scientists Program of the University of Tuebingen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with metastatic uveal melanoma (UM) have a poor prognosis. While long‐term survival data in cutaneous melanoma (CM) are promising, such data are lacking in UM and long‐term survivors are rare. In cases of metastases, the liver is affected in 90% of cases and is the main determinant of life expectancy. Immune checkpoint inhibitors (ICI) are less effective in UM than in CM. Therefore, liver‐directed therapies are of high relevance. We evaluated a large cohort of UM patients ( n = 167) who had developed liver metastases between 2005 and 2021. We focused on patients who survived 3 years or more from the initial diagnosis of liver metastases and precisely characterized this cohort with regard to systemic therapies (ST) and liver‐specific procedures applied. The last follow‐up (FU) date was October 31, 2024. We identified 33 long‐term survivors, representing 20% of the total cohort. Most patients had additional extrahepatic metastases (23/33; 70%), while 10 patients had liver metastases only. First‐line treatment in the metastatic setting consisted of liver‐directed therapies in most of the cases (27/33; 82%). 90% of the patients had received at least one liver‐specific procedure at any time point during FU and 85% had received ICI at any time point. Response evaluation revealed a high percentage of patients with disease control (DC) after the first ST (17/27; 63%) or first liver‐specific therapy (27/29; 93%), respectively. Notably, all patients with chemosaturation as their first liver‐specific procedure achieved DC. Further data are needed on the combination of liver‐directed therapy and ST, such as ICI or Tebentafusp.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaUveal NeoplasmsLiver NeoplasmsCancer SurvivorsHumansUveal MelanomaMaleFemaleMiddle AgedAgedAdultAged, 80 and overPrognosisFollow-Up StudiesRetrospective Studies

Stichwörter der Autor:innen

cancer survivorsliver metastaseslong‐term survivorsmetastatic uveal melanomasurvivorship

Autor:innen und Institutionen

  • Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany.
  • Department of Diagnostic and Interventional Radiology, University Hospital Tuebingen, Tuebingen, Germany.
  • Center of Radiology, Minimally Invasive Therapies and Nuclear Medicine, SLK-Kliniken Heilbronn, Academic Hospital of Ruprecht-Karls-University, Heidelberg, Germany.
  • Department of Nuclear Medicine and Clinical Molecular Imaging, Eberhard Karls University of Tuebingen, Tuebingen, Germany.
  • Department of General, Visceral and Thorax Surgery, Oberschwabenklinik, Ravensburg, Germany.

ORCID-Profile: Andrea Forschner

Förderung

  • Junior Clinician Scientists Program of the University of Tuebingen

Zitieren

APA

Laukhuf, J., Wiens, L., Grözinger, G., Dittmann, H., Thiel, K., Leiter, U., Amaral, T., Nanz, L., Flatz, L., Reitmajer, M., & Forschner, A. (2026). Characterization of long‐term survivors with liver metastases from uveal melanoma diagnosed between 2005 and 2021. International Journal of Cancer. https://doi.org/10.1002/ijc.70246

Vancouver

Laukhuf J, Wiens L, Grözinger G, Dittmann H, Thiel K, Leiter U, et al. Characterization of long‐term survivors with liver metastases from uveal melanoma diagnosed between 2005 and 2021. International Journal of Cancer. 2026. doi:10.1002/ijc.70246

BibTeX
@article{Laukhuf2026,
  author = {Laukhuf, Jona and Wiens, Lisa and Grözinger, Gerd and Dittmann, Helmut and Thiel, Karolin and Leiter, Ulrike and Amaral, Teresa and Nanz, Lena and Flatz, Lukas and Reitmajer, Markus and Forschner, Andrea},
  title = {Characterization of long‐term survivors with liver metastases from uveal melanoma diagnosed between 2005 and 2021},
  journal = {International Journal of Cancer},
  year = {2026},
  doi = {10.1002/ijc.70246}
}
Kostenlos starten →